Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

Completed · Phase 3 · Has a placebo group

Conditions studied: Postmenopausal Women With Osteoporosis

In brief

The purpose of this study is to determine if treatment is effective in preventing fractures in women with postmenopausal osteoporosis.

Key facts

Study ID
NCT01631214
Run by
Amgen
People needed
4093
Starts
2012-05-04
Expected to finish
2017-06-29
Last updated by the study team
2025-02-21

Who can join

Age: 55 and older, up to 90. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.